AS-153: Comparison of Zotarolimus-Eluting Stents Versus Sirolimus-Eluting Stents and Paclitaxel-Eluting Stents for the Treatment of Very Long Lesions: Subgroup Study of the ZEST Trial
β Scribed by Won-Jang Kim; Duk-Woo Park; Young-Hak Kim; Sung-Cheol Yun; Soo-Jin Kang; Seung-Whan Lee; Cheol Whan Lee; Seong-Wook Park; Seung-Jung Park; In-Whan Seong; Jae-Hwan Lee; Seung-Jea Tahk; Myung-Ho Jeong; Yangsoo Jang; Sang-Sig Cheong; Joo-Young Yang; Do-Sun Lim; Ki-Bae Seung; Jei Keon Chae; Seung-Ho Hur; Sang-Gon Lee; Junghan Yoon; Nae-Hee Lee; Young-Jin Choi; Hyun-Sook Kim; Kee-Sik Kim; Hyo-Soo Kim; Taeg Jong Hong; Hun Sik Park
- Book ID
- 113447200
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 182 KB
- Volume
- 105
- Category
- Article
- ISSN
- 0002-9149
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Objective: This study compared the efficacy of the sirolimusβeluting stent (SES), the paclitaxelβeluting stent (PES), and the bare metal stent (BMS) for long coronary lesions. Background: The outcome of drugβeluting stent (DES) implantation in long coronary lesions remains unclear. Meth